酚妥拉明选择性阻断不同物种包括人类的C纤维传导
该研究通过复合动作电位、单纤维记录和膜片钳技术,比较酚妥拉明与利多卡因对小鼠、猪和人类A/C纤维的作用。酚妥拉明浓度依赖性地降低CAP幅度,对C纤维所需浓度显著低于A纤维,且该效应不被α受体激动剂逆转。酚妥拉明抑制大多数C纤维动作电位,对NaV1.8敏感性最高(IC50=10 µM),提示其具有局部麻醉药样特征但受α受体副作用限制。
要点
- 酚妥拉明浓度依赖性地阻断C纤维传导,所需浓度显著低于A纤维。
- 酚妥拉明对C纤维的作用不通过α肾上腺素受体介导。
- 酚妥拉明抑制电压门控钠通道,NaV1.8敏感性最高(IC50=10 µM)。
核心结论
- 酚妥拉明通过抑制电压门控钠通道和动作电位传导,表现出局部麻醉药样特征,但对C纤维作用更强。
研究设计与样本
- 研究比较酚妥拉明与利多卡因对小鼠、猪和人类A型和C型神经纤维复合动作电位幅度的影响。
- 采用野生型和NaV1.8/NaV1.9双敲除小鼠的皮肤-神经标本进行单纤维记录。
- 在ND7/23或HEK293细胞上异源表达电压门控钠通道进行手动和自动全细胞膜片钳电生理实验。
主要发现
- 酚妥拉明浓度依赖性地降低CAP幅度,影响C纤维所需浓度显著低于A纤维。
- 共应用α肾上腺素受体激动剂(R)-(-)-去氧肾上腺素未改变酚妥拉明对CAP的作用。
- 酚妥拉明(100 µM)抑制大多数单单位皮肤C纤维的电诱发动作电位,相同浓度未引起A纤维动作电位消失。
- NaV1.8/NaV1.9双敲除小鼠的C纤维对酚妥拉明敏感性显著低于野生型。
- 膜片钳实验中酚妥拉明浓度依赖性阻断电压门控钠通道,NaV1.8敏感性最高(IC50=10 µM)。
关键数值与推荐
- 酚妥拉明对C纤维的效应显著强于A纤维,所需浓度更低。
- 酚妥拉明100 µM抑制大多数C纤维动作电位,但不引起A纤维动作电位消失。
- 酚妥拉明对NaV1.8的IC50=10 µM。
临床怎么用
- 酚妥拉明可用于探索C纤维功能。
- 全身给药受α肾上腺素能副作用限制。
- 为开发更选择性、强效的镇痛药提供基础。
局限性
- 酚妥拉明对α肾上腺素受体亲和力显著高于电压门控钠通道,全身给药受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Phentolamine is a non-selective competitive α-adrenergic antagonist clinically used to treat different vascular-related diseases. Since recent data suggest an antagonistic effect of phentolamine on voltage-gated sodium channels (VGSCs), further electrophysiological analysis is essential to understand its effects on peripheral sensory nerves. METHODS: We examined the effects of phentolamine on the amplitude of the stimulus-evoked compound action potential (CAP) of A- and C-type nerve fibers derived from mice, pigs, and humans compared with the effects of lidocaine. To explore potential mechanisms of phentolamine action, we performed single nerve fiber recordings using skin-nerve preparations from wild-type and NaV1.8/NaV1.9 double knockout mice, along with manual and automated whole-cell patch-clamp electrophysiology on ND7/23 or HEK293 cells with heterologously expressed VGSCs. RESULTS: Phentolamine decreased CAP amplitudes in a concentration-dependent manner, with significantly lower concentrations needed to affect C-fibers compared with A-fibers. Co-application of the α-adrenergic agonist (R)-(-)-phenylephrine did not alter this effect, suggesting that α-adrenergic receptors do not mediate phentolamine's action in this case. Phentolamine (100 µM) inhibited the electrically evoked action potentials (AP) in the majority of single-unit cutaneous C-fibers, while the same concentration did not provoke AP extinction in A-fibers. C-fibers from NaV1.8/NaV1.9 double knockout mice were significantly less sensitive to phentolamine than those from wild types. In patch-clamp experiments, phentolamine concentration-dependently blocked VGSCs, whereas NaV1.8 showed the highest sensitivity (IC50=10 µM). CONCLUSIONS: Suppressing AP conduction and inhibiting VGSCs, phentolamine exhibits features reminiscent of local anesthetics, but with a stronger effect on C-fibers, which may be attributed to its stronger action on tetrodotoxin-resistant VGSCs. However, due to its markedly higher affinity for α-adrenergic receptors compared with VGSCs, systemic administration of phentolamine is limited by its adrenergic side effects. These findings suggest that phentolamine could be useful for exploring C-fiber function and provide a basis for the development of more selective and potent antinociceptive agents.
引用
- Engler SC, Koulchitsky S, Erickson A, et al. Phentolamine selectively blocks C-fiber conduction in different species, including humans. Reg Anesth Pain Med. 2025. PMID: 40983374. doi:10.1136/rapm-2025-106791
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。